Giancarlo Troncone
Overview
Explore the profile of Giancarlo Troncone including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
319
Citations
4416
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Parente P, Pepe F, Covelli C, Russo G, Russo F, Troncone G, et al.
Pathologica
. 2025 Jan;
116(5):331-334.
PMID: 39748717
No abstract available.
12.
Pisapia P, Iaccarino A, De Luca C, Pepe F, Russo G, Nacchio M, et al.
Pathologica
. 2025 Jan;
116(5):310-319.
PMID: 39748713
Objective: ALK, ROS1, NTRK, and RET gene fusions and MET exon 14 skipping alterations represent fundamental predictive biomarkers for advanced non-small cell lung cancer (NSCLC) patients to ensure the best...
13.
Tommasi S, Coppola C, Caniglia A, Pilato B, Zito F, Carosi M, et al.
Pathologica
. 2025 Jan;
116(5):303-309.
PMID: 39748712
Objective: Prostate cancer (PCa) is the most common cause of cancer-related deaths in men worldwide. BRCA1/2 genes are reported altered in approximately 1% and 8% of PCa cases, respectively. To...
14.
Traversari M, Ventura L, Iwaszczonek A, Cilli E, Longoni M, Pasquinelli G, et al.
Dermatol Reports
. 2024 Dec;
16(4):9956.
PMID: 39669888
Giacomo Torno was born in 1539 (or 1541) in Naples. At the age of 18 he joined the Clerics Regular Theatines in San Paolo Maggiore and was welcomed on 30...
15.
Pepe F, Russo G, Barraco N, Bono M, Listi A, Righi L, et al.
Oncol Ther
. 2024 Nov;
13(1):115-130.
PMID: 39607606
Introduction: Personalized medicine has revolutionized the clinical management of patients with solid tumors. However, the large volumes of molecular data derived from next-generation sequencing (NGS) and the lack of harmonized...
16.
Pisapia P, Russo A, De Luca C, Pepe F, Drago F, Rolfo C, et al.
Lung Cancer
. 2024 Nov;
198:108002.
PMID: 39509773
Introduction: Identifying mutations in the epidermal growth factor receptor (EGFR) gene is crucial for individualized treatment of non-small cell lung cancer (NSCLC) patients. Accordingly, several methodologies and instruments are now...
17.
Vigliar E, Acanfora G, Buono M, Bellevicine C, Picardi M, Troncone G
Cytopathology
. 2024 Nov;
36(1):99-102.
PMID: 39501746
Fine needle cytology (FNC) is a pivotal diagnostic tool for distinguishing between benign and malignant lymphadenopathies mainly because of its minimal invasiveness, cost-effectiveness and accuracy. A major requirement for maximising...
18.
Gristina V, Russo G, Bazan Russo T, Busuito G, Ianni G, Pisapia P, et al.
Expert Rev Respir Med
. 2024 Nov;
18(12):991-1001.
PMID: 39491533
Introduction: In the era of precision medicine, liquid biopsy rapidly emerges as an integrative diagnostic tool to successfully stratify solid tumor patients in accordance with molecular fingerprinting. As the matter...
19.
Gristina V, Bazan Russo T, Barraco N, Gottardo A, Pepe F, Russo G, et al.
Sci Rep
. 2024 Sep;
14(1):22141.
PMID: 39333636
The assessment of ctDNA has emerged as a minimally invasive avenue for molecular diagnosis and real-time tracking of tumor progression in NSCLC. However, the evaluation of ctDNA by amplicon-based NGS...
20.
Buonaiuto R, Neola G, Caltavituro A, Longobardi A, Mangiacotti F, Cefaliello A, et al.
Front Oncol
. 2024 Sep;
14:1412807.
PMID: 39314634
Objective: Preclinical studies have emphasized the potential connection between BRCA specific domains defects and the activity of Poly ADP-ribose polymerase inhibitors (PARPi). Nevertheless, real-world evidence regarding the impact of BRCA...